Perazzolo S, Stephen Z, Eguchi M, Xu X, et al. A novel formulation enabled transformation of 3 HIV drugs tenofovir-lamivudine-dolutegravir (TLD) from short-acting to long-acting all-in-one injectable. AIDS 2023 Aug 25. doi: 10.1097/QAD.0000000000003706.
PMID: 37650755